Carvedilol Tablet, Film Coated
Product Images NDC 60760-494

6 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 60760-494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carv (Carvedilol 60760 494 60)

Carv (Carvedilol 60760 494 60)
Label for Carvedilol tablets, USP, 12.5 mg strength, oral film-coated tablets. The label shows a quantity of 60 tablets with placeholder lot and expiration dates. Manufactured by Cadila Healthcare Ltd., India and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, Arizona. Includes a barcode and a QR code with instructions to "USE AS DIRECTED" and storage temperature guidelines of 15°-30°C (59°-86°F).*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)
Chemical structure of Carvedilol showing its molecular composition with aromatic rings, hydroxyl groups, and ether linkages as depicted in the formula diagram.*
FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)
A line graph showing cumulative mortality percentage over 21 months comparing Carvedilol and placebo groups. The y-axis represents % mortality from 0 to 30, and the x-axis shows time in months from 0 to 21. The Carvedilol group exhibits lower mortality compared to placebo, with a significant p-value (0.0014) indicated on the chart.*
FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)
A forest plot chart showing hazard ratios with confidence intervals for various patient subgroups including gender, age, race, diabetic and ischemic status, heart rate, systolic blood pressure (SBP), and spironolactone use. The chart's horizontal axis represents the hazard ratio, ranging from 0.0 to 2.0.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)
A line graph depicting percentage mortality over a 24-month period comparing Carvedilol tablets 12.5 mg film coated versus placebo. The y-axis shows percentage mortality, and the x-axis shows time in months. The Carvedilol group consistently shows lower mortality than placebo, with a reported P value of 0.03 indicating statistical significance.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)
A forest plot chart depicting hazard ratios for various patient subgroups such as age, gender, prior conditions (CHF, MI), and health factors (hypertension, diabetes). The chart includes subgroup categories on the y-axes and hazard ratio scales on the x-axes, illustrating comparative risk assessments across groups for a clinical study.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.